Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
2018 ◽
Vol 115
(47)
◽
pp. 12046-12050
◽
Keyword(s):
Drugs that treat chronic obstructive pulmonary disease by antagonizing the M3 muscarinic acetylcholine receptor (M3R) have had a significant effect on health, but can suffer from their lack of selectivity against the M2R subtype, which modulates heart rate. Beginning with the crystal structures of M2R and M3R, we exploited a single amino acid difference in their orthosteric binding pockets using molecular docking and structure-based design. The resulting M3R antagonists had up to 100-fold selectivity over M2R in affinity and over 1,000-fold selectivity in vivo. The crystal structure of the M3R-selective antagonist in complex with M3R corresponded closely to the docking-predicted geometry, providing a template for further optimization.
1995 ◽
Vol 270
(30)
◽
pp. 17741-17748
◽
2011 ◽
Vol 162
(7)
◽
pp. 1659-1670
◽
1998 ◽
Vol 34
(3)
◽
pp. 111-122
◽
1999 ◽
Vol 91
(4)
◽
pp. 1014-1014
◽
2020 ◽
Vol 63
(8)
◽
pp. 4349-4369
◽
2006 ◽
Vol 317
(3)
◽
pp. 1134-1142
◽
2020 ◽
Vol 80
◽
pp. 106149
◽